Transplant Diagnostics Market To witness Huge Expansion By 2030

Transplant Diagnostics Industry

The global transplant diagnostics market size is expected to reach USD 9.74 billion by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to the growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, the high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Gather more insights about the market drivers, restrains and growth of the Global Transplant Diagnostics market

Transplant Diagnostics Market Segments Highlights:

The sequencing-based typing segment is anticipated to witness significant growth from 2024 to 2030. High adoption of NGS is a major factor driving segment growth
North America captured the largest revenue share in 2023 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, the medical tourism industry, and awareness regarding organ donation

Transplant Diagnostics Market Report Segmentation

Grand View Research has segmented the global transplant diagnostics market based on test, product, application, transplant area, end use and region:

Transplant Diagnostics Test Outlook (Revenue, USD Million, 2018 - 2030)

Molecular Assays
- PCR-based Molecular Assays
- Real-time PCR
- Sequence-based Primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based Molecular Assays
Sequencing-based Molecular Assays
- Sanger Sequencing
- Next Generation Sequencing
- Other Sequencing-based Molecular Assays
Non-molecular Assays
- Serological Assays
- Mixed Lymphocyte Culture Assays

Transplant Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

Reagents & Consumables
Instruments
Software and Services

Transplant Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)

Diagnostic Application
- Infectious Disease Testing
- Histocompatibility Testing
- Blood Profiling
Research Application

Transplant Diagnostics Transplant Area Outlook (Revenue, USD Million, 2018 - 2030)

Solid Area Transplantation
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Lung Transplantation
- Pancreas Transplantation
- Other Organs Transplantation
Stem Cell Transplantation
Soft Tissue Transplantation
Bone Marrow Transplantation

Transplant Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)